[ad_1]
Hypertension drug looks promising in liver disease (Image Representative) & nbsp | & nbspPhoto: & nbspGetty Images
New York: A drug used to lower blood pressure in the venous system and inflammation could effectively treat life-threatening liver disease, for example, according to researchers, including one of Indian descent. The study on mice showed that the drug sivelestat could reduce portal hypertension, badociated with cirrhosis and other chronic liver diseases, thus improving the symptoms and its course.
Portal hypertension is a condition characterized by an increase in pressure in the portal vein that carries blood from the abdominal organs to the liver. Although there are treatments to treat some forms of liver diseases, including hepatitis C and autoimmune hepatitis, the options for treating portal hypertension have been limited.
"Sivelestat has been safely used in humans with acute lung injury and bronchopulmonary dysplasia, suggesting that Sivelestat and similar drugs are a potential way to reduce portal hypertension in patients with severe pulmonary artery disease." chronic liver disease, "said Vijay Shah, a gastroenterologist at Mayo Clinic in the United States. .
The study, published in the journal Gastroenterology, showed deposits of a protein causing the formation of blood clots contributing to portal hypertension. Fibrin was formed by inflammatory cells known as neutrophils, which, slowed down by the sivelestat, could reduce portal hypertension.
"This study paves the way for the development of new drugs and the reuse of existing compounds to combat liver inflammation caused by mechanical forces related to the disease," said Moira Hilscher, researcher at the University of Toronto. # 39; university. Although the study was obtained from mouse models, it was also confirmed in liver samples taken from humans.
[ad_2]
Source link
